Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2026 Filed Feb 18, 2026 21:21 UTC |
Montarce LucasEVP & CFO
|
Exercise / conversionCommon Stock | 368 | $0.00 | $0.00 |
DisclosureSEC source: 0001752447-26-000004 · wk-form4_1771449713.xml · nonDerivative · entry 1 Montarce Lucas · CIK 0001752447 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,418.206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:21 UTC |
Custer Kenneth L.EVP & President, Card Met Hlth
|
Exercise / conversionRestricted Stock Unit · Derivative | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0002071542-26-000004 · wk-form4_1771449660.xml · derivative · entry 3 Custer Kenneth L. · CIK 0002071542 · EVP & President, Card Met Hlth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 207 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:21 UTC |
Custer Kenneth L.EVP & President, Card Met Hlth
|
Tax withholdingCommon Stock | 91.311 | $1,040.00 | $94,963.44 |
DisclosureSEC source: 0002071542-26-000004 · wk-form4_1771449660.xml · nonDerivative · entry 2 Custer Kenneth L. · CIK 0002071542 · EVP & President, Card Met Hlth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,140.544 Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:21 UTC |
Custer Kenneth L.EVP & President, Card Met Hlth
|
Exercise / conversionCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0002071542-26-000004 · wk-form4_1771449660.xml · nonDerivative · entry 1 Custer Kenneth L. · CIK 0002071542 · EVP & President, Card Met Hlth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,231.855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:19 UTC |
Brown Adrienne SEVP, President LLY Imm
|
Exercise / conversionRestricted Stock Unit · Derivative | 391 | $0.00 | $0.00 |
DisclosureSEC source: 0002096888-26-000004 · wk-form4_1771449581.xml · derivative · entry 3 Brown Adrienne S · CIK 0002096888 · EVP, President LLY Imm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 391 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:19 UTC |
Brown Adrienne SEVP, President LLY Imm
|
Tax withholdingCommon Stock | 169.966 | $1,040.00 | $176,764.64 |
DisclosureSEC source: 0002096888-26-000004 · wk-form4_1771449581.xml · nonDerivative · entry 2 Brown Adrienne S · CIK 0002096888 · EVP, President LLY Imm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,142.342 Read SEC document |
| February 16, 2026 Filed Feb 18, 2026 21:19 UTC |
Brown Adrienne SEVP, President LLY Imm
|
Exercise / conversionCommon Stock | 391 | $0.00 | $0.00 |
DisclosureSEC source: 0002096888-26-000004 · wk-form4_1771449581.xml · nonDerivative · entry 1 Brown Adrienne S · CIK 0002096888 · EVP, President LLY Imm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,312.308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:23 UTC |
Ricks David ADirector · President, Chair, and CEO
|
GrantCommon Stock | 38,913.584 | $1,044.67 | $40,651,853.80 |
DisclosureSEC source: 0001538604-26-000004 · wk-form4_1770844992.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571,715.097 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:27 UTC |
Zakrowski Donald ASVP, Finance, & CAO
|
GrantRestricted Stock Unit · Derivative | 199.472 | $0.00 | $0.00 |
DisclosureSEC source: 0001561539-26-000002 · wk-form4_1770845245.xml · derivative · entry 3 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199.472 Underlying: Common Stock · 199.472 shares Expires 2029-02-16 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:27 UTC |
Zakrowski Donald ASVP, Finance, & CAO
|
GrantCommon Stock | 583.784 | $1,044.67 | $609,861.63 |
DisclosureSEC source: 0001561539-26-000002 · wk-form4_1770845245.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,423.443 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:25 UTC |
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD
|
GrantCommon Stock | 4,865.888 | $1,044.67 | $5,083,247.22 |
DisclosureSEC source: 0001661254-26-000004 · wk-form4_1770845109.xml · nonDerivative · entry 1 Van Naarden Jacob · CIK 0001661254 · EVP,Pres LLY Oncology&HdCorpBD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,626.498 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:17 UTC |
Hakim AnatEVP, GC & Secretary
|
GrantCommon Stock | 8,277.919 | $1,044.67 | $8,647,693.64 |
DisclosureSEC source: 0001685556-26-000004 · wk-form4_1770844627.xml · nonDerivative · entry 1 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,987.024 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:24 UTC |
Skovronsky DanielEVP, CS&PO & Pres. LRL
|
GrantCommon Stock | 15,547.862 | $1,044.67 | $16,242,385.00 |
DisclosureSEC source: 0001741474-26-000004 · wk-form4_1770845058.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · EVP, CS&PO & Pres. LRL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,071.725 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:20 UTC |
Montarce LucasEVP & CFO
|
GrantCommon Stock | 1,365.47 | $1,044.67 | $1,426,465.54 |
DisclosureSEC source: 0001752447-26-000002 · wk-form4_1770844810.xml · nonDerivative · entry 1 Montarce Lucas · CIK 0001752447 · EVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,050.206 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:19 UTC |
Jonsson PatrikEVP & President, LLY Int'l
|
GrantCommon Stock | 4,818.052 | $1,044.67 | $5,033,274.38 |
DisclosureSEC source: 0001786054-26-000004 · wk-form4_1770844753.xml · nonDerivative · entry 1 Jonsson Patrik · CIK 0001786054 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,646.62 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:26 UTC |
Yuffa IlyaEVP&Pres, LLY USA&Global Capab
|
GrantCommon Stock | 4,162.504 | $1,044.67 | $4,348,443.05 |
DisclosureSEC source: 0001826001-26-000004 · wk-form4_1770845161.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,304.111 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:22 UTC |
Rau DiogoEVP & CIDO
|
GrantCommon Stock | 4,432.32 | $1,044.67 | $4,630,311.73 |
DisclosureSEC source: 0001860253-26-000004 · wk-form4_1770844934.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,229.69 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:17 UTC |
Hernandez EdgardoEVP & Pres., Mfg. Operations
|
GrantCommon Stock | 4,383.734 | $1,044.67 | $4,579,555.40 |
DisclosureSEC source: 0001861052-26-000004 · wk-form4_1770844677.xml · nonDerivative · entry 1 Hernandez Edgardo · CIK 0001861052 · EVP & Pres., Mfg. Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,095.717 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:16 UTC |
Dozier EricEVP, Chief People Officer
|
GrantCommon Stock | 3,512.294 | $1,044.67 | $3,669,188.17 |
DisclosureSEC source: 0001955972-26-000004 · wk-form4_1770844572.xml · nonDerivative · entry 1 Dozier Eric · CIK 0001955972 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,936.212 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:14 UTC |
Custer Kenneth L.EVP & President, Card Met Hlth
|
GrantCommon Stock | 659.28 | $1,044.67 | $688,730.04 |
DisclosureSEC source: 0002071542-26-000002 · wk-form4_1770844481.xml · nonDerivative · entry 1 Custer Kenneth L. · CIK 0002071542 · EVP & President, Card Met Hlth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,024.855 Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:12 UTC |
Brown Adrienne SEVP, President LLY Imm
|
GrantCommon Stock | 1,196.308 | $1,044.67 | $1,249,747.08 |
DisclosureSEC source: 0002096888-26-000002 · wk-form4_1770844352.xml · nonDerivative · entry 1 Brown Adrienne S · CIK 0002096888 · EVP, President LLY Imm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,921.308 Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 21:22 UTC Amendment |
Rau DiogoEVP & CIDO
|
GrantCommon Stock | 4,599.164 | $1,044.67 | $4,804,608.66 |
DisclosureSEC source: 0001860253-26-000006 · wk-form4a_1770931366.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,396.534 F1 · shares: This amendment to the Form 4 is being filed to report an adjustment of shares withheld from the Reporting Person to cover tax obligations, which amount was previously over-withheld due to an administrative error. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:29 UTC |
Ricks David ADirector · President, Chair, and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 31,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001538604-26-000002 · wk-form4_1770154157.xml · derivative · entry 8 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,932 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:29 UTC |
Ricks David ADirector · President, Chair, and CEO
|
Tax withholdingCommon Stock | 14,296.654 | $1,037.15 | $14,827,774.70 |
DisclosureSEC source: 0001538604-26-000002 · wk-form4_1770154157.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,801.513 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:29 UTC |
Ricks David ADirector · President, Chair, and CEO
|
Exercise / conversionCommon Stock | 31,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001538604-26-000002 · wk-form4_1770154157.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President, Chair, and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 547,098.167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001661254-26-000002 · wk-form4_1770154258.xml · derivative · entry 5 Van Naarden Jacob · CIK 0001661254 · EVP,Pres LLY Oncology&HdCorpBD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,108 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD
|
Tax withholdingCommon Stock | 1,909.375 | $1,037.15 | $1,980,308.28 |
DisclosureSEC source: 0001661254-26-000002 · wk-form4_1770154258.xml · nonDerivative · entry 2 Van Naarden Jacob · CIK 0001661254 · EVP,Pres LLY Oncology&HdCorpBD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,760.61 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD
|
Exercise / conversionCommon Stock | 4,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001661254-26-000002 · wk-form4_1770154258.xml · nonDerivative · entry 1 Van Naarden Jacob · CIK 0001661254 · EVP,Pres LLY Oncology&HdCorpBD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,669.985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:25 UTC |
Hakim AnatEVP, GC & Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001685556-26-000002 · wk-form4_1770153936.xml · derivative · entry 5 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,700 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:25 UTC |
Hakim AnatEVP, GC & Secretary
|
Tax withholdingCommon Stock | 2,953.395 | $1,037.15 | $3,063,113.62 |
DisclosureSEC source: 0001685556-26-000002 · wk-form4_1770153936.xml · nonDerivative · entry 2 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,709.105 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:25 UTC |
Hakim AnatEVP, GC & Secretary
|
Exercise / conversionCommon Stock | 6,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001685556-26-000002 · wk-form4_1770153936.xml · nonDerivative · entry 1 Hakim Anat · CIK 0001685556 · EVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,662.5 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Skovronsky DanielEVP, CS&PO & Pres. LRL
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001741474-26-000002 · wk-form4_1770154292.xml · derivative · entry 6 Skovronsky Daniel · CIK 0001741474 · EVP, CS&PO & Pres. LRL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,684 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Skovronsky DanielEVP, CS&PO & Pres. LRL
|
Tax withholdingCommon Stock | 5,641.249 | $1,037.15 | $5,850,821.40 |
DisclosureSEC source: 0001741474-26-000002 · wk-form4_1770154292.xml · nonDerivative · entry 2 Skovronsky Daniel · CIK 0001741474 · EVP, CS&PO & Pres. LRL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,523.863 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:31 UTC |
Skovronsky DanielEVP, CS&PO & Pres. LRL
|
Exercise / conversionCommon Stock | 12,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001741474-26-000002 · wk-form4_1770154292.xml · nonDerivative · entry 1 Skovronsky Daniel · CIK 0001741474 · EVP, CS&PO & Pres. LRL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,165.112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:27 UTC |
Jonsson PatrikEVP & President, LLY Int'l
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001786054-26-000002 · wk-form4_1770154060.xml · derivative · entry 4 Jonsson Patrik · CIK 0001786054 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,930 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:27 UTC |
Jonsson PatrikEVP & President, LLY Int'l
|
Tax withholdingCommon Stock | 1,752.071 | $1,037.15 | $1,817,160.44 |
DisclosureSEC source: 0001786054-26-000002 · wk-form4_1770154060.xml · nonDerivative · entry 2 Jonsson Patrik · CIK 0001786054 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,828.568 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:27 UTC |
Jonsson PatrikEVP & President, LLY Int'l
|
Exercise / conversionCommon Stock | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001786054-26-000002 · wk-form4_1770154060.xml · nonDerivative · entry 1 Jonsson Patrik · CIK 0001786054 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,580.639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
Yuffa IlyaEVP&Pres, LLY USA&Global Capab
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001826001-26-000002 · wk-form4_1770154355.xml · derivative · entry 3 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,394 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
Yuffa IlyaEVP&Pres, LLY USA&Global Capab
|
Tax withholdingCommon Stock | 1,512.364 | $1,037.15 | $1,568,548.32 |
DisclosureSEC source: 0001826001-26-000002 · wk-form4_1770154355.xml · nonDerivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,141.607 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC |
Yuffa IlyaEVP&Pres, LLY USA&Global Capab
|
Exercise / conversionCommon Stock | 3,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001826001-26-000002 · wk-form4_1770154355.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,653.971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:28 UTC |
Rau DiogoEVP & CIDO
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001860253-26-000002 · wk-form4_1770154111.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,752 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:28 UTC |
Rau DiogoEVP & CIDO
|
Tax withholdingCommon Stock | 1,673.538 | $1,037.15 | $1,735,709.94 |
DisclosureSEC source: 0001860253-26-000002 · wk-form4_1770154111.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,797.37 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:28 UTC |
Rau DiogoEVP & CIDO
|
Exercise / conversionCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001860253-26-000002 · wk-form4_1770154111.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,470.908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:26 UTC |
Hernandez EdgardoEVP & Pres., Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001861052-26-000002 · wk-form4_1770153992.xml · derivative · entry 4 Hernandez Edgardo · CIK 0001861052 · EVP & Pres., Mfg. Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,572 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:26 UTC |
Hernandez EdgardoEVP & Pres., Mfg. Operations
|
Tax withholdingCommon Stock | 1,591.452 | $1,037.15 | $1,650,574.44 |
DisclosureSEC source: 0001861052-26-000002 · wk-form4_1770153992.xml · nonDerivative · entry 2 Hernandez Edgardo · CIK 0001861052 · EVP & Pres., Mfg. Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,711.983 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:26 UTC |
Hernandez EdgardoEVP & Pres., Mfg. Operations
|
Exercise / conversionCommon Stock | 3,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001861052-26-000002 · wk-form4_1770153992.xml · nonDerivative · entry 1 Hernandez Edgardo · CIK 0001861052 · EVP & Pres., Mfg. Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,303.435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:24 UTC |
Dozier EricEVP, Chief People Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001955972-26-000002 · wk-form4_1770153893.xml · derivative · entry 4 Dozier Eric · CIK 0001955972 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,858 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:24 UTC |
Dozier EricEVP, Chief People Officer
|
Tax withholdingCommon Stock | 1,272.992 | $1,037.15 | $1,320,283.65 |
DisclosureSEC source: 0001955972-26-000002 · wk-form4_1770153893.xml · nonDerivative · entry 2 Dozier Eric · CIK 0001955972 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,423.918 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:24 UTC |
Dozier EricEVP, Chief People Officer
|
Exercise / conversionCommon Stock | 2,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001955972-26-000002 · wk-form4_1770153893.xml · nonDerivative · entry 1 Dozier Eric · CIK 0001955972 · EVP, Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,696.91 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:24 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 9.523 | $1,041.29 | $9,916.20 |
DisclosureSEC source: 0000059478-26-000003 · wk-form4_1769030692.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,110.75 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.